ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Apollo Medical Holdings Inc

Apollo Medical Holdings Inc (AMEH)

40.82
0.00
(0.00%)
Closed June 24 4:00PM
0.00
0.00
(0.00%)

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
17.500.000.000.000.000.000.00 %00-
20.000.000.000.000.000.000.00 %00-
22.500.000.000.000.000.000.00 %00-
25.000.000.000.000.000.000.00 %00-
30.000.000.000.000.000.000.00 %00-
35.000.000.000.000.000.000.00 %00-
40.000.000.000.000.000.000.00 %00-
45.000.000.000.000.000.000.00 %00-
50.000.000.000.000.000.000.00 %00-
55.000.000.000.000.000.000.00 %00-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
17.500.000.000.000.000.000.00 %00-
20.000.000.000.000.000.000.00 %00-
22.500.000.000.000.000.000.00 %00-
25.000.000.000.000.000.000.00 %00-
30.000.000.000.000.000.000.00 %00-
35.000.000.000.000.000.000.00 %00-
40.000.000.000.000.000.000.00 %00-
45.000.000.000.000.000.000.00 %00-
50.000.000.000.000.000.000.00 %00-
55.000.000.000.000.000.000.00 %00-

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AREBAmerican Rebel Holdings Inc
$ 0.76
(152.49%)
371.46M
SHCRSharecare Inc
$ 1.365
(76.27%)
56.33M
NXLNexalin Technologies Inc
$ 1.7499
(59.08%)
57.58M
FUFUBitFuFu Inc
$ 6.1209
(56.95%)
2.5M
SPECSpectaire Holdings Inc
$ 0.50
(47.06%)
65.27M
FLFVFeutune Light Acquisition Corporation
$ 2.5502
(-69.75%)
862.38k
FLFVUFeutune Light Acquisition Corporation
$ 2.75
(-66.83%)
16.5k
RWODRedwoods Acquisition Corporation
$ 2.34
(-60.34%)
155.96k
KAVLKaival Brands Innovations Group Inc
$ 1.23
(-57.14%)
4.92M
RWODURedwoods Acquisition Corporation
$ 3.24
(-56.28%)
1.47k
NVDANVIDIA Corporation
$ 126.57
(-3.22%)
658.13M
AREBAmerican Rebel Holdings Inc
$ 0.76
(152.49%)
371.46M
SIRISirius XM Holdings Inc
$ 2.94
(1.38%)
330.66M
AAPLApple Inc
$ 207.49
(-1.04%)
246.38M
NKLANikola Corporation
$ 0.3466
(5.16%)
193.36M

AMEH Discussion

View Posts
Glider549 Glider549 3 years ago
Anybody else enjoying this ride?
👍️0
Renee Renee 7 years ago
AMEH moved to the Nasdaq from the OTC. Listing is contingent upon merger with Network Medical Management, Inc.

http://otce.finra.org/DLDeletions
👍️0
markkn5 markkn5 9 years ago
Hello out there? Anyone have any information or updates here? Why the limited volume but recent big $$$ purchase? Is something positive in the works? Expansion in marketing efforts to increase new patient admissions? What sort of referral sources are set in place and are any of the companies physician owners utilizing this beneficial practice to increase relationships of the target markets? I think if properly managed here we could see a spike in the price per share. With some positive news from the company we could make our way well back up to the dime spot of $10 ;) holding tight and steady here. Any info helps thanks!
👍️0
markkn5 markkn5 9 years ago
What does this suggest to you? Any insight would be great. Thanks in advance.
👍️0
markkn5 markkn5 9 years ago
Is it true that the director put over $50 million of his own personal money into this company and has never taken any out?
👍️0
markkn5 markkn5 9 years ago
Where are you on this now?
👍️0
markkn5 markkn5 9 years ago
What do you think about this now?
👍️0
markkn5 markkn5 9 years ago
If you have ten minutes of time you really want to have a look at this video about Apollo Medical.

Also I found this from an online article. I would suggest grabbing a hold of this story and seeing what comes of it.

Apollo Medical Holdings, Inc. (AMEH) of the Healthcare sector performed poorly on Thursday with a 7 day performance of 2.56% closing at $8, losing -11.01%. Wallstreet traded at a volume of 100 shares and relative volume of 0.24. Apollo Medical Holdings, Inc. (AMEH) has a quarterly performance of 29.24% and is selling off the company’s 52 week low by 1677.78% . Apollo Medical Holdings, Inc. (AMEH)’s performance per month comes in at 15.11% and has 4.86 million shares outstanding. Apollo Medical Holdings, Inc. (AMEH) is a good stock in the Specialized Health Services industry

👍️0
markkn5 markkn5 9 years ago
Someone bought in nicely today!!!!
👍️0
markkn5 markkn5 9 years ago
I like this. A lot. Great information And an extremely profitable endeavor here. Shares seem to be held SOOOO tight here. Can't wait for the next offering!!!
👍️0
stocktrademan stocktrademan 9 years ago
$AMEH recent news/filings

bullish
bollinger band squeeze
brekaout to the upside
high green volume
symmetrical triangle breakout

## source: finance.yahoo.com

Sat, 18 Jul 2015 17:04:07 GMT ~ APOLLO MEDICAL HOLDINGS, INC. Financials


read full: http://finance.yahoo.com/q/is?s=ameh
*********************************************************

Fri, 17 Jul 2015 00:09:15 GMT ~ 10-K for Apollo Medical Holdings, Inc.


read full: http://www.companyspotlight.com/routers/headline/24299/10004/6536832?cp_code=YAH1&1437091755
*********************************************************

Thu, 16 Jul 2015 16:10:52 GMT ~ RedChip Issues Research Profile on Apollo Medical Holdings

[GlobeNewswire] - ORLANDO, Fla. -- RedChip Companies, Inc., today announced it has issued a research profile on Apollo Medical Holdings, Inc. (OTC:AMEH), an integrated population health management company.

read full: http://finance.yahoo.com/news/redchip-issues-research-profile-apollo-161052914.html
*********************************************************

Wed, 15 Jul 2015 13:00:00 GMT ~ Apollo Medical Holdings Reports 2015 Fiscal Year End Financial Results

[PR Newswire] - GLENDALE, Calif., July 15, 2015 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (OTC-QB: AMEH), an integrated population health management company, today ...

read full: http://finance.yahoo.com/news/apollo-medical-holdings-reports-2015-130000902.html
*********************************************************

Tue, 14 Jul 2015 20:01:37 GMT ~ APOLLO MEDICAL HOLDINGS, INC. Files SEC form 10-K, Annual Report


read full: http://biz.yahoo.com/e/150714/ameh10-k.html
*********************************************************

$AMEH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$AMEH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AMEH/company-info
Ticker: $AMEH
OTC Market Place: OTC Pink Current
CIK code: 0001083446
Company name: Apollo Medical Holdings, Inc.
Company website: http://www.apollomed.net
Incorporated In: DE, USA

$AMEH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001

$AMEH extra dd links

Company name: Apollo Medical Holdings, Inc.
Company website: http://www.apollomed.net

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AMEH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AMEH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AMEH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AMEH/news - http://finance.yahoo.com/q/h?s=AMEH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AMEH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AMEH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AMEH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AMEH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apollo+Medical+Holdings%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apollo+Medical+Holdings%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apollo+Medical+Holdings%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apollomed.net
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apollomed.net#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apollomed.net

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AMEH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001083446&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AMEH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AMEH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AMEH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AMEH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AMEH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AMEH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AMEH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AMEH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AMEH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AMEH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AMEH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AMEH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AMEH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AMEH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AMEH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AMEH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AMEH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AMEH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AMEH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AMEH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AMEH



$AMEH DD Notes ~ http://www.ddnotesmaker.com/AMEH
👍️0
markkn5 markkn5 9 years ago
What's up here?
👍️0
Renee Renee 9 years ago
AMEH one for 10 reverse split:

http://otce.finra.org/DLSymbolNameChanges
👍️0
DaveBlk2714 DaveBlk2714 10 years ago
Have another buy order in. Not gonna gamble with many $s. Rite aid has been a real winner lately and I'm guessing they hooked up with a long term winner.
👍️0
StubbornSOB StubbornSOB 10 years ago
Dave, u r getting scam. They got to make monies hoping u would sell quickly after this price drop IMPO, but hang tight there.
👍️0
DaveBlk2714 DaveBlk2714 10 years ago
Stuck my toes in this one yesterday based on the Rite Aid news. Any thoughts out there?
👍️0
dollarman1 dollarman1 11 years ago
Wth happened here?
👍️0
Hegotgame Hegotgame 12 years ago
Apollo Medical Holdings Expands Services into Orange County
Company
Announces The Appointment of Daniel Hilton, M.D. As Regional Hospitalist Medical
Director


GLENDALE, Calif., Oct. 9, 2012 /PRNewswire via COMTEX/ -- Apollo Medical
Holdings, Inc. ("ApolloMed") (OTCQB-AMEH), a leading provider of hospitalist,
critical care, ACO and multi-disciplinary care management services in Southern
and Central California, today announced that it has entered the Orange County
market and has appointed Daniel Hilton, M.D. as Regional Hospitalist Medical
Director.

ApolloMed will initially have 24/7 presence at four Orange County hospitals:
Fountain Valley Regional Medical Center, a 400-bed full-service acute care
facility owned by Tenet Healthcare Corporation and one of the largest hospitals
in the county, Huntington Beach Hospital, a 131-bed facility owned by Prime
Healthcare, Kindred Hospital in Westminster, a 99-bed long term acute care
(LTAC) facility and Kindred Hospital in Santa Ana, a 54-bed LTAC facility. Both
LTACs are owned by Kindred Healthcare, the largest diversified provider of
post-acute care services in the U.S. ApolloMed now provides hospitalist services
at 27 hospitals in Central and Southern California.

Dr. Hilton is an experienced hospitalist leader who is highly respected in the
communities he serves. He currently serves as Chief of Medicine at Fountain
Valley Regional Medical Center, Chair of the Department of Infectious Diseases
at Huntington Beach Hospital and Chief of Staff at Kindred Hospital in
Westminster. In his new role as the Regional Hospitalist Medical Director for
Orange County, Dr. Hilton will be responsible for all operational aspects of
ApolloMed's hospitalist programs.

Dr. Hilton completed his internship and residency in internal medicine at
LAC-USC Medical Center. He is board certified in internal medicine and has a
special interest in palliative care medicine.

"The Orange County market is strategically very important for ApolloMed and
existing clients have asked us to offer our services in Orange County. We
anticipate additional contracts with new clients and providing them best in
class care," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo
Medical Holdings, Inc. "We are also very proud that Daniel has decided to join
us and lead our efforts in Orange County. He is a fine clinician and has
demonstrated superb leadership qualities."

"I'm very excited to join the ApolloMed team," stated Daniel Hilton, M.D.,
Regional Hospitalist Medical Director. "I am eager to advance ApolloMed's
integrated health care delivery model here in Orange County."

About Apollo Medical Holdings, Inc.

ApolloMed is a leading provider of integrated medical management services that
improves the quality and efficiency of inpatient hospital care plus
multi-disciplinary care management services targeting inefficiencies in
healthcare payer and provider networks. ApolloMed ACO, a subsidiary of the
Company, was one of only eight ACOs in California selected by CMS in 2012 to
participate in the Medicare Shared Savings Program. The Company's integrated
model combines hospitalist medicine, critical care medicine, 24-hour physician
call centers, case management and transition management that offers to help
healthcare organizations engage in performance payments for utilization
efficiency, quality of care objectives and shared accountability arrangements.

For more information, please visit our website: www.apollomed.net

Media Contact:

Nidia FloresApollo Medical Holdings, Inc.(818) 396-8050nflores@apollomed.net

SOURCE Apollo Medical Holdings, Inc.



www.prnewswire.com


Copyright (C) 2012 PR Newswire. All rights reserved

-0-
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
I do not not think he is involved,as least not since middle of 2011. My not so fat fingers,just kept on hitting the buy orders 2 weeks ago,as a result I had to file a 13g yesterday. I ready like the company using my "2008 INMG template",with/without beer goggle...return/risk is so attractive:I'm in LOVE.........you have a great weekend!!!
👍️0
10 bagger 10 bagger 12 years ago
DJRT.. Does ivan cassell still own 8%.. ??? hank
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
I got a BAD BAD BAD feeling about this one. The use of derivative most likely be the straw that breaks the camel's back,66% chance likely within 4Q-6Q. I'm happy you got out with a PROFIT and smell like roses!!

ps- Officially I'm a Sugar Daddy/Pimp??? of djrt.
👍️0
10 bagger 10 bagger 12 years ago
As you know I got out whole on the last pump of over 300K waiting for the pot of gold at the end of the rainbow.. I was waiting to see how long it would take you to post what you did,, but I'm glad that after 2!/2 years of prodding by you I saw the light..

I actually made over $65K trading over those years so all was not lost but I gave up several times because of the $0.125 options.. I made only $14K on the pump because I got out far too soon.. hank
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
Bad Signs and bad fundamentals..................
Share increase of 7% to 31,015,904 from 28,985,774;
Loss on change in fair value of derivative liabilities -$2,914,549;
................
................
Business model is definitely flawed and the management needs a wholesale change!! Until then,watch and "no touching".
👍️0
10 bagger 10 bagger 12 years ago
APOLLO MEDICAL HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)



Three months ended July 31, Six months ended July 31,
2012 2011 2012 2011

REVENUES $ 1,649,451 $ 1,093,708 $ 3,281,295 $ 2,133,400
COST OF SERVICES 1,205,673 939,336 2,534,332 1,886,825
GROSS PROFIT 443,778 154,371 746,963 246,575

Operating expenses:
General and administrative 501,858 235,130 853,405 511,485
Depreciation 4,946 2,580 9,737 5,873
Total operating expenses 506,804 237,710 863,142 517,358

LOSS FROM OPERATIONS (63,026 ) (83,339 ) (116,179 ) (270,783 )

Other income (expense)
Loss on change in fair value of derivative liabilities (2,914,549 ) - (2,790,711 ) -
Interest expense (205,221 ) (31,603 ) (408,047 ) (63,177 )
Financing cost (19,685 ) (9,375 ) (40,895 ) (18,750 )
Other income 455 1,484 450 2,546
Total other expenses (3,139,000 ) (39,494 ) (3,239,203 ) (79,381 )

LOSS BEFORE INCOME TAXES (3,202,026 ) (122,833 ) (3,355,382 ) (350,164 )

Provision for Income Tax 800 - 4,800 1,600

NET LOSS $ (3,202,826 ) $ (122,833 ) $ (3,360,182 ) $ (351,764 )

WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING,
BASIC AND DILUTED 31,015,904 28,985,774 30,780,543 28,819,752

BASIC AND DILUTED NET LOSS PER SHARE $ (0.10 ) $ (0.00 ) $ (0.11 ) $ (0.01 )



👍️0
10 bagger 10 bagger 12 years ago
That is becaused it was crossed inhouse and they didn't have to go to an outside market.. 300 shares at $0.47,, It prob. was crossed at Nite..hank
👍️0
rado rado 12 years ago
Strange, I had a limit order set to sell at .28 and today I got a partial fill at .47. I don't mind, but that doesn't seem to make sense.
👍️0
rado rado 12 years ago
Thanks 10bagger. I had no idea. My order is for less than 5000. I'm just trying to get rid of what I have left.
👍️0
10 bagger 10 bagger 12 years ago
If your order is for less than 5000 shares you will have to wait until it is bid there... hank
👍️0
rado rado 12 years ago
I have had a limit order at .28 since sitting there since last week, yet today I'm seeing a trade at .55 How is that possible?
👍️0
rado rado 12 years ago
I sold half of mine at .50. Took a couple days to get filled though. Whoever is buying is chewing through things very slowly. Hank you think this is someone who owns options trying to raise the price for awhile so that AMEH options convert?
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
Did a quick tally,someone drove up the stock price,with less than 80k shares purchased above $0.20 pps. Last batch of shares traded below $0.20 pps was on 7/16/2012,after ???? scooped up all the shares below that price......a SLICK FISH is here in the pond and to stay.......size,duration,and intention are all unknown.

ps-big fish and no fundamental(being naked) do not mix well for minnows!!
👍️0
10 bagger 10 bagger 12 years ago
I never look backwards.. If I wasn't out of the office for a couple of day's they would of had it all at the conversion price of $0.125.. Someone is marking this one up and when they are done for what ever reason TIMBER.. hank
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
Water under the bridge,GONE,move on. I'm pretty sure there are more 10-baggars out on the field WAITING for pickin........keep on TRYING and stay FOCUSED!

ps-ameh:high risk: Kyle is way too smart/"Wall Street" for any of us.
👍️0
10 bagger 10 bagger 12 years ago
I guess they got me out of the way.. Read my last few posts.. hank
👍️0
mooremi9 mooremi9 12 years ago
AMEH .50!!!!!!!!! what the heck happened?
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
Never felt right with Kyle,former healthcare fund manager,and "business model of 1%-2% net at best" he represented; therefore "watch and no touching!"; also their style is Too "Wall Street" for me to sleep well at night!!

There is an "old sore thumb" stock flirting at me,no makeup,no body,and no.....; but its kind of cute(beer goggle) once you are used to it,and started liking it more and more;it may just pull itself out of the dump and ?????? The stock is our "old flame":djrt.....coming to life and sexy?????

ps- Problem: without beer goggle,I still like it: LOVE!!! I'm in trouble. I guess it is my term to be the "Sugar Daddy!"
👍️0
10 bagger 10 bagger 12 years ago
AMEH $0.63.. WOW..... I waited almost 3 years with a position as high as 450K and it appears I read too much into thier last Q and K filings.. They have massive Conv. Debt to covert at $0.125 and they haven't made a dime on thier services whi;e increasing Revs. almost 8 times.. Management changes have occured each year and funding has come from usury types and are/is loaded with dilution.. I'm out and my guess is the new group of Debt providers are trying to force conversion of the older group..

I sold with an AVE. of $0. 153 and had a cost basis of less than $0. 09.. and watched it go from there to $0.2788 and back to $0.05 when it was a better company.. The thing that pisses me off is that I could of had a great rush today with AMEH trading on a mark up to above $0.60 plus.. I tried to borrow stock to short but it appears I was the only one at E-Trade that had a position.. Moving on will be easy as I'm sure that the $0.63 print will not remain long.. hank
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
I'm clueless and way off on this one too.....my fundamental approach has limitations but it protects me from the downside....I respect your 2 1/2 year duration and played the role of MM...I hope WFCF and others can make up for the shortfall soon!!

Fish that got away: PSGY;IVDN;.....but too few to mention!!

ps-I still got my rod,plenty of bait,and a stack of "kitchen pass!"
👍️0
budge budge 12 years ago
AMEH.....wtf?
👍️0
10 bagger 10 bagger 12 years ago
AMEH.. $0.188 I'm almost gone..

It's taken 2 1/2 years to get out of this one .. I hade 490,000 shares at the beginning of April and they have a business model that doesn't work,, Besides there is debt Conv. at $0.125 and it's now looking to get reg.. Have 27,500 left.. My ave cost was less then $0.10.. BUT... Watched it go up w/o out reducing my position.. Made sales as high as $0.2788 but always replaced.. I guess I was in love with AMEH.. Was in love with a stock,, the easiest way to go broke .. hank

👍️0
10 bagger 10 bagger 12 years ago
AMEH.. $0.1188..Apollo Medical Holdings, Inc. Reports Revenues and Results of Operations for Three Months Ended April 30, 2012

PR Newswire - Jun 22 09:00 EDT

GLENDALE, Calif., June 22, 2012 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB-AMEH) today announced financial results for the three months ended April 30, 2012.

Financial Highlights for the three months ended April 30, 2012

Revenues increased 56.7% to $1.63 million for the three months ended April 30, 2012 compared to $1.04 million for the three months ended April 30, 2011
Gross profit increased 228.8% to $303,185 for the three months ended April 30, 2012 compared to $92,204 for the three months ended April 30, 2011
Loss from operations was ($53,153) for the three months ended April 30, 2012 compared to ($187,444) for the three months ended April 30, 2011
Non-GAAP Adjusted EBITDA was $55,772 for the three months ended April 30, 2012 compared to ($113,818) for the three months ended April 30, 2011
Other Events

ApolloMed continues to advance its business through new contracts and partnerships centered around medical management. As an example, in the first quarter, ApolloMed expanded 24 hour hospitalist service at five hospitals in the Covina, West Covina and Glendora areas of Los Angeles. We expect volume to continue to grow over time as existing partners leverage our presence at all our hospitals. ApolloMed is also pursuing a number of new health plan and hospital contracts.

In addition to growing our core hospitalist business, we continue to explore new opportunities to leverage our market leading medical management expertise. In the first quarter, ApolloMed management invested in creating a new entity focused on obtaining a designation as an Accountable Care Organization ("ACO") as defined under the Medicare Shared Savings Program ("MSSP"). We believe that in establishing an ACO, ApolloMed will be able to leverage its medical management service offering and networks to improve patient outcomes while controlling costs. ACOs participating in the MSSP will be able to share up to 50% of their achieved savings.

"We are pleased to report another quarter of record revenue and continued quarter over quarter growth," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. "We will continue to execute on our strategy of organic growth. In addition, we believe that our coordinated care model and expertise in caring for medically complex patients makes us an excellent candidate to participate in the MSSP."


About Apollo Medical Holdings, Inc.

ApolloMed is a leading provider of integrated medical management services that improves the quality and efficiency of inpatient hospital care plus multi-disciplinary care management services targeting inefficiencies in healthcare payer and provider networks. The Company's integrated model combines hospitalist medicine, critical care medicine, 24-hour physician call centers, case management and transition management that offers to help healthcare organizations engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. The company's strategy is to capitalize on the growing market for hospital-based physicians and care management services.



Media Contact:

Nidia Flores
Apollo Medical Holdings, Inc.
818-396-8050
www.apollomed.net





SOURCE Apollo Medical Holdings, Inc.





👍️0
10 bagger 10 bagger 12 years ago
AMEH.. $0.10.. 10Q For the three months ended April 30, 2012

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following management’s discussion and analysis should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in this Quarterly Report. In addition, reference is made to our audited consolidated financial statements and notes thereto and related Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our most recent Annual Report on Form 10-K for the year ended January 31, 2012, filed with the Securities and Exchange Commission ( SEC) on May 15, 2012.

In this Quarterly Report, unless otherwise expressly stated or the context otherwise requires, “Apollo,” “we,” “us” and “our” refer to Apollo Medical Holdings, Inc,, a Delaware corporation, and its wholly-owned subsidiary-management company, Apollo Medical Management, Inc., and affiliated medical groups. Our affiliated professional organizations are separate legal entities that provide physician services in California and with which we have management agreements. For financial reporting purposes we consolidate the revenues and expenses of all our practice groups that we own or manage because we have a controlling financial interest in these practices based on applicable accounting rules and as described in our accompanying financial statements. Also, unless otherwise expressly stated or the context otherwise requires, “our affiliated hospitalists” refer to physicians employed or contracted by either our wholly-owned subsidiaries or our affiliated professional organizations. References to “practices” or “practice groups” refer to our subsidiary-management company and the affiliated professional organizations of Apollo that provide medical services, unless otherwise expressly stated or the context otherwise requires.

The following discussion contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding future events and the future results of Apollo that are based on management’s current expectations, estimates, projections, and assumptions about our business. Words such as “may,” “will,” “could,” “should,” “target,” “potential,” “project,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “sees,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including, but not limited to, those discussed in our most recent Annual Report on Form 10-K, including the section entitled “Risk Factors”, as well as those discussed from time to time in the Company’s other SEC filings and reports. In addition, such statements could be affected by general industry and market conditions. Such forward-looking statements speak only as of the date of this Quarterly Report or, in the case of any document incorporated by reference, the date of that document, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this Report, or for changes made to this document by wire services or Internet service providers. If we update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections with respect to other forward-looking statements.

Overview

We are a leading provider of hospitalist services in the Greater Los Angeles, California area. Hospitalist medicine is organized around the admission and care of patients in an inpatient facility such as a hospital or skilled nursing facility and is focused on, managing and coordinating the care of hospitalized patients.

Executive Summary

For the three months ended April 30, 2012, the Company’s executive management and certain of our physicians were focused on several forward-looking initiatives, including efforts in obtaining Company designation as an Accountable Care Organization (“ACO”) as defined under the Medicare Shared Savings Program (Section 3022 of the PPACA) (“MSSP”). The ACO concept places a degree of financial responsibility on the providers in hopes of improving care management and limiting unnecessary expenditures while continuing to provide patients freedom to selection of their medical services. The Company believes that in establishing an ACO, ApolloMed will be able to leverage its medical management expertise to efficiently managed patient’s costs through improved communication between physicians and their patients, which should lead to improved patient outcomes and lower readmission rates. The Company is working closely with the Center for Medicare and Medicaid Services, and we expect to hear a response to our ACO application in the second or third quarter of fiscal 2013. ACOs participating in the shared-savings payment model will be able to share in up to 50 percent of their achieved savings, depending on how well they exceed minimum quality performance standards. If successful in obtaining a ACO designation, ApolloMed may be required to raise additional capital to fund this opportunity.

We incurred a loss from operations of $53,153 for the three months ended April 30, 2012, compared to a loss from operations of $187,444 for the three months ended April 30, 2011. To date the Company has funded its operations from internally generated cash flow and external sources, the proceeds from the Senior Secured Note and the proceeds available from the private placement of convertible notes which have provided funds for near-term operations and growth. The current operating plan indicates that losses from operations may be incurred for all of fiscal 2013 and maturing debt in fiscal 2013 totaling $1,520,000. Consequently, we may not have sufficient liquidity necessary to sustain operations for the next twelve months and this raises substantial doubt that we will be able to continue as a going concern. The Company intends to seek raise additional capital through public or private equity financings, partnerships, joint ventures, disposition of assets, debt financings, bank borrowings or other sources of financing.

No assurances can be made that management will be successful in achieving its plan. If the Company is not able to raise substantial additional capital in a timely manner, the Company may be forced to cease operations.

Results of Operations and Operating Data

Three Months Ended April 30, 2012 vs. Three Months Ended April 30, 2011

Net revenues for the three months ended April 30, 2012 of $1,631,844 increased $592,151, or 57 percent, over net revenues of $1,039,693 reported for the three months ended April 30, 2011 due to the Company’s acquisitions and growth of fee for service revenues in new attributable to new hospital contracts, and expansion of services with existing medical group clients at new hospitals. Net revenues are comprised of net billings under the various fee structures from health plans, medical groups/IPA’s and hospitals, and income from service fee agreements.

Cost of services includes the payroll and consulting costs of the physicians, all payroll related costs, costs for all medical malpractice insurance and physician privileges. Cost of services was $1,328,659 for the three months ended April 30, 2012,or 84% of revenues, compared to $947,849 for the three months ended April 30, 2011, or 91% of revenues. The increase of $381,170 is attributable to $239,299 increase in physician costs attributable to new physicians hired to support new contracts, $36,441 increase in non-cash stock compensation, $33,402 increase related to the acquisition of PCCM and consolidation of LALC, and $72,028 in other cost related to supporting growth in new contracts and expansion of services.

General and administrative expenses include all salaries, benefits, supplies and operating expenses, not specifically related to the day-to-day operations of our physician group practices, including billing and collections functions, and our corporate management and overhead. During the three months ended April 30, 2012, the Company’s executive management and certain of our physicians were active in seeking Company ACO designation. General and administrative expenses were $351,547, or 22% of revenues, for the three months ended April 30, 2012 compared to $276,355 for the three months ended April 30, 2011, or 27% of revenues. The increase of $75,192 is primarily the result of an increase in professional fees of $20,365 costs to support the continuing growth of our operations, $16,683 increase in salaries and wages to support in-house medical billing initiative, $6,500 increase in compensation due to the addition of two new directors to the Company’s board of directors, $20,680 in additional administrative expenses due to the acquisition of PCCM and consolidation of LALC, and $10,964 in additional support other Company initiatives.

Depreciation and amortization expense was $4,791 for the three months ended April 30, 2012, and $3,293 for the three months ended April 30, 2011, primarily due to the addition of the Company’s investment in a new billing system.

Loss from operations was $53,153 for the three months ended April 30, 2012 compared to a loss from operations of $187,444 in the same period in 2011, a decrease of $134,291 due to improvements in 2012 revenues and gross profit while adding contracts with hospitals, IPAs and Health plans and the hiring of several additional physicians.

Gain on change in fair value of warrant and derivative liabilities of $123,838 for three months ended April 30, 2012 reflects the change in the fair value of the Company’s warrant and derivative liabilities at April 30, 2012 and January 31, 2012.

Interest expense and financing cost was $224,036 for the three months ended April 30, 2012, compared to $40,949 for the three months ended April 30, 2011. The increase of $183,087 was due to higher discount amortization $163,458, higher interest expense due to the Senior Secured Notes $16,835, and $7,794 due to other borrowings.

Net loss was $157,356 for the three months ended April 30, 2012, compared to a net loss of $228,930 for the three months ended April 30, 2011. The decrease in the net loss of $71,574 is primarily related to increase in revenue growth and lower cost of services as a percentage of revenue.

Liquidity and Capital Resources

At April 30, 2012, the Company had cash and cash equivalents of $193,931, compared to cash and cash equivalents of $164,361 at January 31, 2012. The Company has borrowings totaling $1,520,000 that mature within one year and $150,000 in long-term borrowings at April 30, 2012.

Three months ended April 30, 2012

For the three months ended April 30, 2012, cash used in operations was $131,160. This was substantially a result of net losses of 157,356, cash used in working capital of $143,599, partially offset by non-cash expenses of $169,755. Non-cash expenses primarily include depreciation, issuance of shares of common stock for service, stock option compensation expense, amortization of financing costs, amortization of debt discount, and gain on change in fair value of warrant and derivative liabilities. Cash was used for working capital due to an increase in trade receivables of $152,404, an increase in due from affiliates of $2,425, an increase in financing costs of $5,000, and increase in prepaid expenses and advances of $3,963 and an increase in other assets of $1,450; partially offset by a net increase in due to officers of $6,604, and an increase in accounts payable and accrued liabilities of $15,619.

For the three months ended April 30, 2012, cash used in investing activities was $9,270 related to the Company’s investment in a new billing system and office technology equipment.

For the three months ended April 30, 2012, cash provided by financing activities was $270,000 related to proceeds from the Senior Secured Note. Borrowings were used primarily to fund working capital requirements and technology investments.

Three months ended April 30, 2011

Net cash used in operating activities totaled $114,432 in the three months ended April 30, 2011, compared to net cash used in operations of $155,830 for the comparable three months ended April 30, 2010. The decrease in accounts receivable and increase in and increase in accounts payable, is the primary cause for the decrease in cash used for operating activities and transaction and start-up losses related with acquisition of AHI for the three months ended April 30, 2010.

During the three months ended April 30, 2011, the Company advanced $800 to an affiliated Company. The Company invested $4,568 to develop a web site and an $800 advance to an affiliated Company in the first quarter of 2010.

The Company had $193,931 in cash and cash equivalents at April 30, 2012. We incurred a loss from operations of $53,153 for the three months ended April 30, 2012. To date the Company has funded its operations from internally generated cash flow and external sources, the proceeds from the Senior Secured Note and the proceeds available from the private placement of convertible notes which have provided funds for near-term operations and growth. The current operating plan indicates that losses from operations may be incurred for all of fiscal 2013 and maturing debt in fiscal 2013 totaling $1,520,000. Consequently, we may not have sufficient liquidity necessary to sustain operations for the next twelve months and this raises substantial doubt that we will be able to continue as a going concern. The Company intends to seek raise additional capital through public or private equity financings, partnerships, joint ventures, disposition of assets, debt financings, bank borrowings or other sources of financing. No assurances can be made that management will be successful in achieving its plan. If the Company is not able to raise substantial additional capital in a timely manner, the Company may be forced to cease operations.



👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
For quite some times,one of my concern about this company/stock: Is the business model flawed and management in denial??

"....Apollo Medical Holdings, Inc. Reports Record Revenues for Fiscal Year ended January 31, 2012..."

10Q ER released to the public was misleading and it should had been corrected as follow

"....Apollo Medical Holdings, Inc. Reports Record Revenues and RECORD LOSSES for Fiscal Year ended January 31, 2012..."

Kyle: Don't you know which way is up?? The way you presented the report was unprofessional and bordering on dishonesty: Shape up or ship out!!

A closer look at 4Q and see why:
Revenue: $1.55 million;
Cost: $1.14 million(74%);
SG&A: $0.673 million(43%);
Income before tax: loss of $0.423 million.

My god,this baby is in trouble: more the revenues,higher the losses!!!

ps- Long term players,get out now;Kyle is beating on a DEAD HORSE!!


👍️0
mooremi9 mooremi9 12 years ago
Apollo Medical Holdings, Inc. Reports Record Revenues for Fiscal Year ended January 31, 2012

http://money.msn.com/business-news/article.aspx?feed=PR&Date=20120516&ID=15119876&topic=TOPIC_SMALL_CAP&isub=2
👍️0
10 bagger 10 bagger 12 years ago
AMEH.. $0.1288 Could they finally be turning this thing around..??

ApolloMed Selected by Care1st Health Plan to Provide Hospitalist Services to Its Members at Fifteen Hospitals Throughout Los Angeles County

GLENDALE, Calif., March 16, 2012 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-AMEH.PK), a leading provider of hospitalist, critical care and integrated medical management services in California, today announced that ApolloMed Hospitalists, one of its affiliated medical groups, signed a service agreement with Care1st Health Plan to provide inpatient care services to its members at 15 hospitals throughout Los Angeles County.

Care1st, based in Monterey Park, CA, is a regional health plan that provides health care benefits to a combined membership of 350,000 patients in California and Arizona. Initially begun as a Medi-Cal plan in 1994, Care1st expanded into a full service health plan that now offers multiple products, including Medicare Advantage.

"Care1st is well-known in the community as a leading health plan that delivers quality care throughout its network to its members," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc. "We look forward to working with management to improve patient care and efficiencies."

About Apollo Medical Holdings, Inc.

ApolloMed is a leading provider of integrated medical management services that improves the quality and efficiency of inpatient hospital care plus multi-disciplinary care management services targeting inefficiencies in healthcare payer and provider networks. The Company's integrated model combines hospitalist medicine, critical care medicine, 24-hour physician call centers, case management and transition management that offers to help healthcare organizations engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. The company's strategy is to capitalize on the growing market for hospital-based physicians and care management services. There are currently 4900 acute care hospitals in the U.S., with more than 35 million annual admissions. Total U.S. spending on hospital care currently exceeds $650 billion, and is expected to increase to $1.3 trillion by 2016. ApolloMed is located in Glendale, CA and has over 40 contracts with health plans, hospitals and medical groups in Los Angeles County and in Central California.

For more information, please visit our website: www.apollomed.net

Media Contact:
Erik Deutsch Nidia Flores
ExcelPR Group Apollo Medical Holdings, Inc.
(323) 851-2300 x 112 (818) 396-8050
(310) 597-9245 (Cell) nflores@apollomed.net
erikd@excelpr.com



SOURCE Apollo Medical Holdings, Inc.


👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
Unregistered Sales of Equity Securities and more:
http://biz.yahoo.com/e/120313/ameh.pk8-k.html

Just wondering how many more shares to be added in 2012,in the name of restructuring,going on for 4 years: 10%????? 66% chance.

Will cost be stabilized at 75% and lower soon?? Kyle has few more quarters left to showcase his effort: working or beating on a SICK horse.
👍️0
10 bagger 10 bagger 12 years ago
100,000 traded today @$0.08 and then it was marked up to $0.1188,, my offer but I didn't see the trade.. hank
👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
"...Mr. Augusta's investment firm - SpaGus Capital Partners - has agreed to provide ApolloMed with working capital...."

Again,my concerns of this baby w/growing pain and new management in training :
1. Dilution had gone as high as 6-8% per past years..it is way too much already and MORE coming??
2. Is Kyle working for shareholders or his investment friends?? We shall know soon by what the cost(cheap/expensive) of the new capital is;and get to see where his royalty lies.
3. Business model is challenged: M&A(growth) through debt financing;high cost structure(75%-90%);bad macro;CASH STRAPPED balance sheet w/HIGH A/R;.......worst case scenario: business model flawed and management is beating on a dead horse!

On a positive note:
Last Q it had a small profit,trend or aberration??

👍️0
10 bagger 10 bagger 12 years ago
AMEH $0.10..

Apollo Medical Holdings, Inc. Appoints Gary Augusta to Board of Directors... Finance and Business Development Expert Will Help Drive Healthcare Services Growth...

GLENDALE, Calif., March 7, 2012 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-AMEH), a leading provider of hospitalist, critical care and multi-disciplinary care management services to the healthcare community, today announced the appointment of Gary Augusta to its Board of Directors. In addition, Mr. Augusta's investment firm - SpaGus Capital Partners - has agreed to provide ApolloMed with working capital.

Mr. Augusta brings more than 20 years of experience as an executive focused on private equity, growth strategy, operations, corporate development and M&A at companies ranging from start-up ventures to Fortune 500 companies. He is also an experienced investor and operator of growth businesses.

"Gary brings a wide scope of experience and expertise that will help ApolloMed earn a growing share of the $650 billion spent annually in the U.S. on inpatient hospital care," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc. "His hands-on approach, business and investor network and ability to execute will benefit us tremendously."

Mr. Augusta currently serves as President of SpaGus Ventures LLC and SpaGus Capital Partners, growth funds that invest in life sciences and technology companies. He previously co-founded and served as President and CEO of OCTANe, an innovation development corporation formed to start and fund biomedical, technology, green tech and other types of innovative startup companies.

"I look forward to working with Warren and the talented ApolloMed team to help take the company to the next level," stated Gary Augusta. "ApolloMed's unique patient-centric, results-driven inpatient and post-discharge care delivery model positions it as a leader in this market."

Earlier in his career, Mr. Augusta was Vice President of M&A and Corporate Development at engineering and construction giant Fluor, where he focused on internal new business creation and mergers and acquisitions. Prior to his tenure at Fluor, he served as a principal at global management consulting firm A.T. Kearney, where he focused on growth strategy, operational improvement and change management assignments for clients including Prudential Healthcare, FedEx, Wachovia and many others.

Other posts include serving as Executive Director of the OCTANe Foundation for Innovation, and member of the UC Irvine CEO Roundtable, the Keck Graduate Institute Advisory Council and the UC Irvine Advisory Boards for both the School of Engineering and the School of Information & Computer Science. He serves as a board member or advisor to several start-up companies in the biomedical and technology industries, as well as board director for a publicly traded micro-cap company.

Mr. Augusta resides in Southern California. He earned a BS in Mechanical Engineering from the University of Rhode Island and a Master of Science and Management (MSM) from Georgia Tech.

About Apollo Medical Holdings, Inc.

ApolloMed is a leading provider of integrated medical management services that improve the quality and efficiency in inpatient hospital care. The Company's integrated model combines hospitalist medicine, critical care medicine, 24-hour physician call centers, case management and transition management. Its mission is to improve care and efficiency, while helping healthcare organizations engage in performance payments and shared accountability arrangements. The company's strategy is to capitalize on the growing market for hospital-based physician and care management services. There are currently 4,900 acute care hospitals in the U.S., with more than 35 million annual admissions. Total U.S. spending on hospital care currently exceeds $650 billion and is expected to increase to $1.3 trillion by 2016. For more information, please visit www.apollomed.net.



Media Contacts:

Erik Deutsch
ExcelPR Group (for ApolloMed)
(323) 851-2300 x112
erikd[at]excelpr[dot]com

Nidia Flores
Operations Manager
Apollo Medical Holdings, Inc.
(818) 844-3881
n.flores[at]apollomed[dot]net



SOURCE Apollo Medical Holdings, Inc.


👍️0
greasemonkeyshoes greasemonkeyshoes 12 years ago
I have followed this baby almost as long as you had.Why I'm standing on the sideline: management,management,and management;with the change of Chairman of the board and prior promotion of Kyle,the company is addressing and restructuring its next generation management team,a positive sign,but in a terrible business environment.

Current concerns:
Due to draconian budget cuts,the health care system in California is likely be challenged for years to come;on top of that,expansion thru debt/equity have not been favorable/fair to old investors. I have spoken to Kyle sometime ago and expressed my concerns;I do not think he had the gripe yet and needed time to work things out.

NO ECONOMY OF SCALE:
Unless cost is down below 80%,I watch only!
👍️0

Your Recent History

Delayed Upgrade Clock